Literature DB >> 2837540

Cuprizone neurotoxicity in the rat: morphologic observations.

S Love1.   

Abstract

Weanling male Wistar rats fed a diet containing 0.5-2% cuprizone developed intramyelinic edema of the cerebellar white matter, hilum of the dentate nucleus and superior cerebellar peduncle. Oligodendrocytes in these regions showed hyperchromatic nuclei and abnormally dense cytoplasm, with an increase in the number of free ribosomes and enlargement of mitochondria. Unlike the lesions produced by cuprizone in weanling mice, those in the rat did not lead to demyelination. Cuprizone caused a distal peripheral axonopathy, with degeneration of myelinated axons in the sciatic nerve but preservation of the spinal nerve roots, dorsal root ganglia, posterior spinal funiculi and anterior horn cells. Unmyelinated fibers were largely spared. Some axonal regeneration occurred despite the continued administration of cuprizone. The intramyelinic edema and the nuclear and cytoplasmic abnormalities of the oligodendrocytes disappeared after the resumption of a normal diet.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837540     DOI: 10.1016/0022-510x(88)90127-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

2.  Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.

Authors:  Alexandra Taraboletti; Tia Walker; Robin Avila; He Huang; Joel Caporoso; Erendra Manandhar; Thomas C Leeper; David A Modarelli; Satish Medicetty; Leah P Shriver
Journal:  Biochemistry       Date:  2017-02-28       Impact factor: 3.162

Review 3.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

4.  Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.

Authors:  Sean R Werner; Joy K Saha; Carol L Broderick; Eugene Y Zhen; Richard E Higgs; Kevin L Duffin; Rosamund C Smith
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

5.  Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats.

Authors:  Justin R Gregg; Nicole R Herring; Alipi V Naydenov; Ryan P Hanlin; Christine Konradi
Journal:  Schizophr Res       Date:  2009-07-01       Impact factor: 4.939

Review 6.  Myelin, copper, and the cuprizone model of schizophrenia.

Authors:  Nicole R Herring; Christine Konradi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

7.  Microbial Neuraminidase Induces a Moderate and Transient Myelin Vacuolation Independent of Complement System Activation.

Authors:  Pablo Granados-Durán; María Dolores López-Ávalos; Manuel Cifuentes; Margarita Pérez-Martín; María Del Mar Fernández-Arjona; Timothy R Hughes; Krista Johnson; B Paul Morgan; Pedro Fernández-Llebrez; Jesús M Grondona
Journal:  Front Neurol       Date:  2017-03-07       Impact factor: 4.003

8.  Strain differences in cuprizone induced demyelination.

Authors:  Qili Yu; Ryan Hui; Jiyoung Park; Yangyang Huang; Alexander W Kusnecov; Cheryl F Dreyfus; Renping Zhou
Journal:  Cell Biosci       Date:  2017-11-03       Impact factor: 7.133

9.  Neuroprotective effect of newly synthesized 4-aminopyridine derivatives on cuprizone-induced demyelination in mice-a behavioral and immunohistochemical study.

Authors:  Ivanka Kostadinova; Boycho Landzhov; Lyubomir Marinov; Lyubomir Vezenkov; Nikolai Danchev
Journal:  Amino Acids       Date:  2021-07-08       Impact factor: 3.520

Review 10.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.